Skip to main content
Erschienen in: Virchows Archiv 6/2012

01.12.2012 | Original Article

BMI1 expression identifies subtypes of Merkel cell carcinoma

verfasst von: Maria Kouzmina, Valtteri Häyry, Junnu Leikola, Caj Haglund, Tom Böhling, Virve Koljonen, Jaana Hagström

Erschienen in: Virchows Archiv | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine carcinoma. The aims of this study were to investigate the expression of the transcription factors B-lymphoma Moloney murine leukaemia virus insertion (BMI1), myelocytomatosis viral oncogene homologue (c-Myc) and Snail in MCC tumour specimens and to examine the relationship of these markers to Merkel cell polyoma virus (MCV). The study comprised of 133 patients with primary MCC. The expression of BMI1, Snail and c-Myc protein was assessed by immunohistochemistry and compared with clinical parameters, MCV status and patient survival. The presence of MCV was inversely correlated with the expression of BMI1 protein. Tumours expressing BMI1 protein more often presented with lymph node metastases. Snail protein expression was decreased in cases with metastatic dissemination. This study identified two subgroups of MCC: tumours expressing BMI1 but negative for MCV DNA and tumours negative for BMI1 expression but positive for MCV. Importantly, BMI1-positive cases often presented with lymph node metastases. Combined, these results suggest that subtypes of this malignancy exist.
Literatur
1.
Zurück zum Zitat Szeder V, Grim M, Kucera J et al (2003) Neurotrophin-3 signaling in mammalian Merkel cell development. Dev Dyn 228:623–629PubMedCrossRef Szeder V, Grim M, Kucera J et al (2003) Neurotrophin-3 signaling in mammalian Merkel cell development. Dev Dyn 228:623–629PubMedCrossRef
2.
Zurück zum Zitat Lucarz A, Brand G (2007) Current considerations about Merkel cells. Eur J Cell Biol 86:243–251PubMedCrossRef Lucarz A, Brand G (2007) Current considerations about Merkel cells. Eur J Cell Biol 86:243–251PubMedCrossRef
3.
Zurück zum Zitat Winkelmann RK (1977) The Merkel cell system and a comparison between it and the neurosecretory or APUD cell system. J Invest Dermatol 69:41–46PubMedCrossRef Winkelmann RK (1977) The Merkel cell system and a comparison between it and the neurosecretory or APUD cell system. J Invest Dermatol 69:41–46PubMedCrossRef
4.
Zurück zum Zitat Grim M, Halata Z (2000) Developmental origin of avian Merkel cells. Anat Embryol (Berl) 202:401–410CrossRef Grim M, Halata Z (2000) Developmental origin of avian Merkel cells. Anat Embryol (Berl) 202:401–410CrossRef
5.
Zurück zum Zitat Sidhu GS, Chandra P, Cassai ND (2005) Merkel cells, normal and neoplastic: an update. Ultrastruct Pathol 29:287–294PubMedCrossRef Sidhu GS, Chandra P, Cassai ND (2005) Merkel cells, normal and neoplastic: an update. Ultrastruct Pathol 29:287–294PubMedCrossRef
6.
Zurück zum Zitat Compton CC, Regauer S, Seiler GR et al (1990) Human Merkel cell regeneration in skin derived from cultured keratinocyte grafts. Lab Invest 63:233–241PubMed Compton CC, Regauer S, Seiler GR et al (1990) Human Merkel cell regeneration in skin derived from cultured keratinocyte grafts. Lab Invest 63:233–241PubMed
7.
Zurück zum Zitat Brown JA, Smoller BR (2009) Merkel cell carcinoma: what is it, what will it do and where will it go? What role should the pathologist play in reporting this information? J Cutan Pathol 36:924–927PubMedCrossRef Brown JA, Smoller BR (2009) Merkel cell carcinoma: what is it, what will it do and where will it go? What role should the pathologist play in reporting this information? J Cutan Pathol 36:924–927PubMedCrossRef
9.
Zurück zum Zitat Hwang JH, Alanen K, Dabbs KD et al (2008) Merkel cell carcinoma with squamous and sarcomatous differentiation. J Cutan Pathol 35:955–959PubMedCrossRef Hwang JH, Alanen K, Dabbs KD et al (2008) Merkel cell carcinoma with squamous and sarcomatous differentiation. J Cutan Pathol 35:955–959PubMedCrossRef
10.
Zurück zum Zitat Saeb-Lima M, Montante-Montes de Oca D, Albores-Saavedra J (2008) Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases. Ann Diagn Pathol 12:410–414PubMedCrossRef Saeb-Lima M, Montante-Montes de Oca D, Albores-Saavedra J (2008) Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases. Ann Diagn Pathol 12:410–414PubMedCrossRef
11.
Zurück zum Zitat Cooper L, Debono R, Alsanjari N et al (2000) Merkel cell tumour with leiomyosarcomatous differentiation. Histopathology 36:540–543PubMedCrossRef Cooper L, Debono R, Alsanjari N et al (2000) Merkel cell tumour with leiomyosarcomatous differentiation. Histopathology 36:540–543PubMedCrossRef
12.
Zurück zum Zitat Eusebi V, Damiani S, Pasquinelli G et al (2000) Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of three cases. Am J Surg Pathol 24:223–230PubMedCrossRef Eusebi V, Damiani S, Pasquinelli G et al (2000) Small cell neuroendocrine carcinoma with skeletal muscle differentiation: report of three cases. Am J Surg Pathol 24:223–230PubMedCrossRef
13.
Zurück zum Zitat Tan KB, Murali R, Karim RZ et al (2008) Merkel cell carcinoma with fibrosarcomatous differentiation. Pathology 40:314–316PubMedCrossRef Tan KB, Murali R, Karim RZ et al (2008) Merkel cell carcinoma with fibrosarcomatous differentiation. Pathology 40:314–316PubMedCrossRef
14.
Zurück zum Zitat Van Keymeulen A, Mascre G, Youseff KK et al (2009) Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol 187(1):91–100PubMedCrossRef Van Keymeulen A, Mascre G, Youseff KK et al (2009) Epidermal progenitors give rise to Merkel cells during embryonic development and adult homeostasis. J Cell Biol 187(1):91–100PubMedCrossRef
15.
Zurück zum Zitat Vaigot P, Pisani A, Darmon YM et al (1987) The majority of epidermal Merkel cells are non-proliferative: a quantitative immunofluorescence analysis. Acta Derm Venereol 67:517–520PubMed Vaigot P, Pisani A, Darmon YM et al (1987) The majority of epidermal Merkel cells are non-proliferative: a quantitative immunofluorescence analysis. Acta Derm Venereol 67:517–520PubMed
16.
Zurück zum Zitat Moll I, Zieger W, Schmelz M (1996) Proliferative Merkel cells were not detected in human skin. Arch Dermatol Res 288:184–187PubMedCrossRef Moll I, Zieger W, Schmelz M (1996) Proliferative Merkel cells were not detected in human skin. Arch Dermatol Res 288:184–187PubMedCrossRef
17.
Zurück zum Zitat Ezeh UI, Turek PJ, Reijo RA et al (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104:2255–2265. doi:10.1002/cncr.21432 PubMedCrossRef Ezeh UI, Turek PJ, Reijo RA et al (2005) Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104:2255–2265. doi:10.​1002/​cncr.​21432 PubMedCrossRef
23.
Zurück zum Zitat Mihic-Probst D, Kuster A, Kilgus S et al (2007) Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer 121:1764–1770. doi:10.1002/ijc.22891 PubMedCrossRef Mihic-Probst D, Kuster A, Kilgus S et al (2007) Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer 121:1764–1770. doi:10.​1002/​ijc.​22891 PubMedCrossRef
28.
Zurück zum Zitat Feng H, Shuda M, Chang Y et al (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–1100PubMedCrossRef Feng H, Shuda M, Chang Y et al (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–1100PubMedCrossRef
29.
Zurück zum Zitat Foulongne V, Kluger N, Dereure O et al (2008) Merkel cell polyomavirus and Merkel cell carcinoma, France. Emerg Infect Dis 14:1491–1493PubMedCrossRef Foulongne V, Kluger N, Dereure O et al (2008) Merkel cell polyomavirus and Merkel cell carcinoma, France. Emerg Infect Dis 14:1491–1493PubMedCrossRef
30.
Zurück zum Zitat Becker JC, Houben R, Ugurel S et al (2009) MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 129:248–250PubMedCrossRef Becker JC, Houben R, Ugurel S et al (2009) MC polyomavirus is frequently present in Merkel cell carcinoma of European patients. J Invest Dermatol 129:248–250PubMedCrossRef
31.
Zurück zum Zitat Sihto H, Kukko H, Koljonen V et al (2009) Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101:938–945PubMedCrossRef Sihto H, Kukko H, Koljonen V et al (2009) Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 101:938–945PubMedCrossRef
32.
Zurück zum Zitat Garneski KM, Warcola AH, Feng Q et al (2009) Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol 129:246–248PubMedCrossRef Garneski KM, Warcola AH, Feng Q et al (2009) Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol 129:246–248PubMedCrossRef
33.
Zurück zum Zitat Shuda M, Feng H, Kwun HJ et al (2008) T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 105:16272–16277PubMedCrossRef Shuda M, Feng H, Kwun HJ et al (2008) T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 105:16272–16277PubMedCrossRef
35.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC (eds) (2010) Merkel cell carcinoma. Springer, New York, pp 315–323 Edge SB, Byrd DR, Compton CC (eds) (2010) Merkel cell carcinoma. Springer, New York, pp 315–323
36.
Zurück zum Zitat Brunner M, Thurnher D, Pammer J et al (2008) Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma. Mod Pathol 21:876–884PubMedCrossRef Brunner M, Thurnher D, Pammer J et al (2008) Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma. Mod Pathol 21:876–884PubMedCrossRef
40.
Zurück zum Zitat Miller RW, Rabkin CS (1999) Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 8:153–158PubMed Miller RW, Rabkin CS (1999) Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 8:153–158PubMed
41.
Zurück zum Zitat Tai PT, Yu E, Winquist E et al (2000) Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 18:2493–2499PubMed Tai PT, Yu E, Winquist E et al (2000) Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 18:2493–2499PubMed
43.
Zurück zum Zitat Lee K, Adhikary G, Balasubramanian S et al (2008) Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J Invest Dermatol 128:9–17. doi:10.1038/sj.jid.5700949 PubMedCrossRef Lee K, Adhikary G, Balasubramanian S et al (2008) Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis. J Invest Dermatol 128:9–17. doi:10.​1038/​sj.​jid.​5700949 PubMedCrossRef
44.
Zurück zum Zitat Cohen KJ, Hanna JS, Prescott JE et al (1996) Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity. Mol Cell Biol 16:5527–5535PubMed Cohen KJ, Hanna JS, Prescott JE et al (1996) Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity. Mol Cell Biol 16:5527–5535PubMed
45.
Metadaten
Titel
BMI1 expression identifies subtypes of Merkel cell carcinoma
verfasst von
Maria Kouzmina
Valtteri Häyry
Junnu Leikola
Caj Haglund
Tom Böhling
Virve Koljonen
Jaana Hagström
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 6/2012
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-012-1327-7

Weitere Artikel der Ausgabe 6/2012

Virchows Archiv 6/2012 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …